GSK1059615
GSK1059615 is a research compound that has been investigated in clinical trials for various cancers, including lymphoma, solid tumors, endometrial cancer, and metastatic breast cancer. It functions as a potent and selective PI3K inhibitor, with studies demonstrating its activity in both in vitro cellular assays and in vivo tumor models.
Product Specifications
CAS Number
958852-01-2
Product Name Alternative
Inhibit, mTOR, GSK1059615, GSK-1059615, GSK 1059615, Inhibitor, Mammalian target of Rapamycin, Apoptosis, PI3Kγ, PI3Kβ, PI3Kδ, PI3Kα, PI3K, Phosphoinositide 3-kinase
Field of Research
Cell Biology, Signal Transduction
Purity
≥95% (May vary between batches)
Solubility
DMSO:5 mg/mL (15 mM)
Smiles
O=C1NC (=O) \C (S1) =C\c1ccc2nccc (-c3ccncc3) c2c1
Molecular Formula
C18H11N3O2S
Molecular Weight
333.36
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb2907325-01 20 µg
Recombinant Gluconacetobacter diazotrophicus Undecaprenyl-diphosphatase (uppP)
Sign In for Pricing
View Details orb2907325-02 100 µg
Recombinant Gluconacetobacter diazotrophicus Undecaprenyl-diphosphatase (uppP)
Sign In for Pricing
View Details 
MBS6362678-01 0.2 mL
VN1R5, ID (VN1R5, V1RL5, Vomeronasal type-1 receptor 5, G-protein coupled receptor GPCR26, V1r-like receptor 5) (FITC)
Sign In for Pricing
View Details